Meril Life Sciences launches indigenously developed bioresorbable scaffold

This novel therapy option, which can meaningfully treat an identified subset of the patient population, will be launched in a phased, sequential manner to ensure adherence to best clinical practices and continued development of clinical research and long-term evidence, Meril Life Sciences said in a statement.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3eoWxZG
via IFTTT